Teladoc Health (NYSE:TDOC) Stock Passes Below 50 Day Moving Average – What’s Next?

Teladoc Health, Inc. (NYSE:TDOC) shares crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $5.13 and traded as low as $5.06. Teladoc Health shares last traded at $5.0950, with a volume of 3,329,660 shares changing hands.

Wall Street Analysts Forecast Growth

TDOC has been the subject of several research reports. JPMorgan Chase & Co. reduced their price target on shares of Teladoc Health from $9.00 to $7.00 and set a “neutral” rating for the company in a research report on Friday, March 13th. Wells Fargo & Company reduced their price target on shares of Teladoc Health from $8.00 to $6.00 and set an “equal weight” rating for the company in a research report on Thursday, February 26th. Bank of America upgraded shares of Teladoc Health from a “neutral” rating to a “buy” rating and set a $7.00 target price for the company in a research report on Thursday, February 26th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Teladoc Health in a research note on Friday, March 27th. Finally, Barclays reduced their target price on shares of Teladoc Health from $8.50 to $7.00 and set an “equal weight” rating for the company in a research note on Thursday, March 26th. Six investment analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $7.64.

Teladoc Health Price Performance

The stock has a market cap of $919.29 million, a PE ratio of -4.47 and a beta of 2.07. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.77 and a quick ratio of 2.67. The firm’s 50 day moving average price is $5.13 and its two-hundred day moving average price is $6.71.

Teladoc Health (NYSE:TDOC) last posted its earnings results on Wednesday, February 25th. The health services provider reported ($0.14) earnings per share for the quarter, topping the consensus estimate of ($0.19) by $0.05. The firm had revenue of $642.27 million during the quarter, compared to the consensus estimate of $635.33 million. Teladoc Health had a negative net margin of 7.92% and a negative return on equity of 9.13%. The company’s revenue was up .3% on a year-over-year basis. During the same quarter last year, the company earned ($0.28) earnings per share. Teladoc Health has set its Q1 2026 guidance at -0.450–0.350 EPS and its FY 2026 guidance at -1.100–0.700 EPS. On average, research analysts expect that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Insider Activity at Teladoc Health

In other news, CEO Charles Divita III sold 27,731 shares of the firm’s stock in a transaction that occurred on Wednesday, March 11th. The shares were sold at an average price of $5.49, for a total value of $152,243.19. Following the completion of the transaction, the chief executive officer directly owned 364,784 shares in the company, valued at approximately $2,002,664.16. This trade represents a 7.06% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.58% of the company’s stock.

Hedge Funds Weigh In On Teladoc Health

Large investors have recently modified their holdings of the company. PNC Financial Services Group Inc. boosted its position in shares of Teladoc Health by 177.7% in the fourth quarter. PNC Financial Services Group Inc. now owns 4,391 shares of the health services provider’s stock valued at $31,000 after acquiring an additional 2,810 shares during the period. IFP Advisors Inc boosted its position in shares of Teladoc Health by 412.1% in the third quarter. IFP Advisors Inc now owns 3,989 shares of the health services provider’s stock valued at $31,000 after acquiring an additional 3,210 shares during the period. Aster Capital Management DIFC Ltd boosted its position in shares of Teladoc Health by 101.1% in the third quarter. Aster Capital Management DIFC Ltd now owns 4,823 shares of the health services provider’s stock valued at $37,000 after acquiring an additional 2,425 shares during the period. International Assets Investment Management LLC bought a new position in shares of Teladoc Health in the fourth quarter valued at approximately $45,000. Finally, Bayforest Capital Ltd bought a new position in shares of Teladoc Health in the third quarter valued at approximately $58,000. 76.82% of the stock is currently owned by institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.